+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

Chronic Idiopathic Urticaria - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Idiopathic Urticaria - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
From
Dystrophic Epidermolysis Bullosa - Pipeline Insight, 2024 - Product Thumbnail Image

Dystrophic Epidermolysis Bullosa - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 75 Pages
  • Global
From
Nail Diseases - Pipeline Insight, 2024 - Product Thumbnail Image

Nail Diseases - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Atopic Dermatitis - Pipeline Insight, 2024 - Product Thumbnail Image

Atopic Dermatitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 240 Pages
  • Global
From
Bacterial Skin Diseases - Pipeline Insight, 2024 - Product Thumbnail Image

Bacterial Skin Diseases - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Common Warts - Pipeline Insight, 2024 - Product Thumbnail Image

Common Warts - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Deep Partial-Thickness Thermal Burns - Pipeline Insight, 2024 - Product Thumbnail Image

Deep Partial-Thickness Thermal Burns - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Hidradenitis Suppurativa - Pipeline Insight, 2024 - Product Thumbnail Image

Hidradenitis Suppurativa - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 115 Pages
  • Global
From
Dyschromia - Pipeline Insight, 2024 - Product Thumbnail Image

Dyschromia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Phototherapies for Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Phototherapies for Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Prurigo Nodularis - Pipeline Insight, 2024 - Product Thumbnail Image

Prurigo Nodularis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Psoriasis vulgaris - Pipeline Insight, 2024 - Product Thumbnail Image

Psoriasis vulgaris - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Systemic Scleroderma - Pipeline Insight, 2024 - Product Thumbnail Image

Systemic Scleroderma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Tinea Pedis - Pipeline Insight, 2024 - Product Thumbnail Image

Tinea Pedis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Warts - Pipeline Insight, 2024 - Product Thumbnail Image

Warts - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Skin Burns - Pipeline Insight, 2024 - Product Thumbnail Image

Skin Burns - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Skin Neoplasms - Pipeline Insight, 2024 - Product Thumbnail Image

Skin Neoplasms - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Localized Scleroderma - Pipeline Insight, 2024 - Product Thumbnail Image

Localized Scleroderma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Moderate to Severe Inflammatory Acne Vulgaris - Pipeline Insight, 2024 - Product Thumbnail Image

Moderate to Severe Inflammatory Acne Vulgaris - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more